For a complete list of publications from our team see this page.
Changing the specialist mental health care: The Concentrated Treatment Format
The team was newly awarded funding for the study «Changing the specialist mental health care: The Concentrated Treatment Format ». The study will compare The Bergen 4-day format to treatment as usual in five disorders; panic disorder, social anxiety disorder, generalized anxiety disorder, depression and body dysmorphic disorder.
The Bergen 4-day treatment for OCD: A randomized trial
Professor Gerd Kvale and associate professor Bjarne Hansen at the OCD-team at Haukeland University Hospital, have developed a concentrated format (The Bergen 4-day treatment) of delivering exposure based treatment. The format is now being evaluated in a randomized trial.
The difficult to treat anxiety patient: New treatment approaches: A multicenter study
Our multicenter study investigates if the combination of concentrated, prolonged exposure-based treatment (The Bergen 4-day treatment) and the NMDA agonist d-cyloserine (DCS), enhance and stabilize treatment effects for difficult to treat patients.
Sleep disturbance in treatment-seeking OCD-patients
Although we have a fair amount of knowledge regarding obsessive-compulsive disorder (OCD) and the treatment, little is known about sleep patterns in patients with the disorder. Does sleep patterns affects treatment outcome or change as a result of treatment.
Brain plasticity and the Bergen 4-day format: Changes in the brain after concentrated exposure treatment for OCD
Concentrated exposure treatment (cET) helps many patients with OCD to recover, but what happens in the brain when they do so? The OCD-team is currently completing the first study able to measure changes in the brain directly after treatment.
OCD: Novel Comparative Genomic Approaches to Identify Disease and Treatment Mechanisms
The study aim to markedly increasing the worldwide sample size for genomic analysis, in a first step toward elucidating the fundamental biology of this condition.